SCHEMBL7806557

SCHEMBL7806557

CCCCCCCCCCCCCCCC=C/C=C\C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.67
FASN P49327 1/20 0.67
KDM4E B2RXH2 1/20 0.65
CNR1 P21554 2/20 0.57
CNR2 P34972 2/20 0.57
FAAH O00519 2/20 0.56
TERT O14746 2/20 0.55
GMNN O75496 1/20 0.55
USP2 O75604 1/20 0.55
LMNA P02545 1/20 0.55
CYP1A2 P05177 1/20 0.55
POLB P06746 1/20 0.55
MAPT P10636 1/20 0.55
CYP2C9 P11712 1/20 0.55
ALOX15 P16050 1/20 0.55
APEX1 P27695 1/20 0.55
CYP2C19 P33261 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2785794 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL6556128 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL1614406 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL2059489 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL3793137 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL23067684 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL17540751 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL2453148 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL21411170 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2
SCHEMBL1614408 1.00 PTPN1 (0.67) PTPN1FASNKDM4ECNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 CN claimed
CN-116287276-A Liver cancer biological marker and application thereof 浙江大学医学院附属第一医院 2023-06-23 CN claimed
CN-116287276-A Liver cancer biological marker and application thereof 浙江大学医学院附属第一医院 2023-06-23 CN disclosed
CN-115774059-A Alzheimer disease biomarker and screening method and application thereof 中国科学院深圳先进技术研究院 2023-03-10 CN disclosed
CN-104619311-A Vesicular formulations, kits and uses SEQUESSOME TECHNOLOGY HOLDINGS LTD 2015-05-13 CN disclosed
CN-104411298-A Vesicular formulations, uses and methods SEQUESSOME TECHNOLOGY HOLDINGS LTD 2015-03-11 CN disclosed
CN-1290823-C Ketol fatty acid amide derivatives and plant growth regulators SHISEIDO CO LTD (JP) 2006-12-20 CN disclosed
CN-1680287-A Ketol fatty acid amide derivatives and plant growth regulators SHISEIDO CO LTD (JP) 2005-10-12 CN disclosed
CN-1210278-C Ketol fatty acid derivatives, preparation method and plant growth regulator SHISEIDO CO LTD (JP) 2005-07-13 CN disclosed
CN-1419555-A Ketol fatty acid derivatives and plant growth regulators SHISEIDO CO LTD (JP) 2003-05-21 CN disclosed
EP-0926951-A4 METHODS OF TREATING PULMONARY DISEASES MEDIATED BY POLYUNSATURATED LIPID METABOLITES AND ASSAYS FOR EPOXIDE HYDROLASE INHIBITORS UNIV CALIFORNIA (US) 2001-08-08 EP disclosed
EP-0926951-A1 METHODS OF TREATING PULMONARY DISEASES MEDIATED BY POLYUNSATURATED LIPID METABOLITES AND ASSAYS FOR EPOXIDE HYDROLASE INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-07-07 EP disclosed
WO-1998006261-A1 METHODS OF TREATING PULMONARY DISEASES MEDIATED BY POLYUNSATURATED LIPID METABOLITES AND ASSAYS FOR EPOXIDE HYDROLASE INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-02-19 WO disclosed